← Open Payments lookup

SYDNEY WORD: Open Payments

NPI 1760122162 · RUSSELLVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$444 in 28 payments from 11 companies in 2025. Trend: 2023 $158 · 2024 $371 · 2025 $444

Food & beverage: $444
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)13$136
Salix Pharmaceuticals, a division of Bausch Health US, LLC4$88
Otsuka America Pharmaceutical, Inc.2$49
ABBVIE INC.2$47
Vanda Pharmaceuticals Inc.1$28
Phathom Pharmaceuticals, Inc.1$20
Alkermes, Inc.1$17
Corcept Therapeutics1$16
AstraZeneca Pharmaceuticals LP1$16
Cranial Technologies, Inc1$14

Products named: CAPLYTA, XIFAXAN, REXULTI, FANAPT, QULIPTA, VRAYLAR, VOQUEZNA, ARISTADA.

Industry payments across KY — which companies pay providers there.